UTD vs HER2.eSPR macrophage treatment in MC38.HER2 TIL
Ontology highlight
ABSTRACT: Here, exploiting myeloid antibody-dependent cellular phagocytosis biology and phagocytosis checkpoint blockade, we report an enhanced synthetic phagocytosis receptor (eSPR) that integrates FcRγ-driven phagocytic chimeric antigen receptors (CARs) with built-in secreted CD47 blockers. To assess modulation of the tumor immune microenvironment by eSPR macrophages, untreated (UTD) and eSPR-macrophage-treated tumor tissues were extracted and processed. CD45⁺ tumor-infiltrating leukocytes were sorted and analyzed by single-cell RNA sequencing.
ORGANISM(S): Mus musculus
PROVIDER: GSE293891 | GEO | 2025/04/26
REPOSITORIES: GEO
ACCESS DATA